{'fraction_non_alphanumeric': 0.06785243741765482, 'fraction_numerical': 0.04413702239789196, 'mean_word_length': 3.980327868852459, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of antisense oligodeoxynucleotide directed to NF-kappa B-RelA on Bcl-XL mRNA in extended drug resistance leukemia cell line HL-60/E6.

To explore the effect of NF-kappa B on bcl-x gene transcription in extended drug resistance leukemia cell line HL-60/E6, drug-resistant subline HL-60/E6 was derived by intermittently exposing HL-60 cells to 6 ng/ml epirubicin. Indirect immunofluorescence was used to demonstrate the location of NF-kappa B-RelA in HL-60/E6 cells. FCM analysis and RT-PCR were used to detect the efficiency of liposome-mediated ODN transfection and the change of bcl-XL mRNA levels after 5 mumol/L phosphorothioate (PS)-derivatized antisense (AS) oligodeoxynucleotide (ODN) directed to RelA was transferred into HL-60/E6 cells. The results showed that RelA remained persistently active and located at the nuclei of HL-60/E6 cells, but in the cytoplasm of HL-60 cells, the efficiency of liposome-mediated ODN transfection was significantly higher than that of null ODN (P < 0.01 in 4 h, 6 h, 12 h, 24 h). Exposure of HL-60/E6 cells to 5 mumol/L AS-PS-ODN directed to RelA led to a maximal 40% decline of bcl-XL mRNA levels within 8 h. The inhibition rate of bcl-XL mRNA was (15 +/- 1.79)%, (28 +/- 2.34)%, (40 +/- 3.47)%, (20 +/- 1.54)%, in 4 h, 6 h, 8 h, 15 h, respectively, but it was less than 15% in control group. It was concluded that NF-kappa B was involved in regulating bcl-x transcription. It was suggested that NF-kappa B was an important factor for drug resistance in leukemia cells.